Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

A Chicago woman who has struggled with Type 1 diabetes since childhood is now off insulin, thanks to doctors at the ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

The drug, tegoprubart, was the same one used in the first transplant of a pig kidney into a human patient earlier in 2024. In ...

Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...

He said the weekly injections and easy-to-use injection ... to spend $30 billion on factories to make all its medications, including insulin, the company told lawmakers. "We will keep producing ...

Insulin injections can’t mimic the responsiveness ... It’s harder to make needed adjustments “when you’re committing to a medication that is injected once a week,” Romeo says.

He said the weekly injections and easy-to-use injection pens have made weight-loss drugs more appealing to patients. The ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...